Jakob Dynnes Hansen

Jakob Dynnes Hansen

More than 25 years of experience from biotech and financing. Previously, CFO of Evolva, a Swiss public biotech company, Nuevolution and Zealand Pharma, Senior member of Corporate Finance Team at Unibank (now Nordea), Head of Market Research at Novo Nordisk. MSc (Econ.,University of Copenhagen), MBA (INSEAD).